In attempt to develop a novel anti-metastasis therapy for prostate cancer, we utilized the newly established saRNA technique to up-regulate the expression of tumor metastasis suppressor DPYSL3 gene. The gene discussed is DPYSL3; the disease is prostate carcinoma.